J TELMI Plus Tablet 80/12.5 mg (Telmisartan, Hydrochlorothiazide)
Telmisartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
MFDS item code 201907015 · Approved 2019.10.02
This product's status changed to Expired on 2024.10.02. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not adequately controlled with telmisartan alone
This medication is used for the treatment of essential hypertension and is administered additionally to patients whose blood pressure cannot be adequately controlled with Telmisartan alone. This helps lower blood pressure effectively and aids in the prevention of complications related to hypertension.
Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this medicine, in which the doses of each component are fixed, it is recommended to adjust and administer the dose of each component separately for each patient. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered as separate products or as a combination product. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance <30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Do not administer more than 40/12.5mg of this medicine daily to patients with mild to moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment. Thiazide diuretics should be administered with caution in patients with hepatic impairment. Elderly patients No dose adjustment is required.
The safety and efficacy of this medicine have not been established in children under 18 years of age.
This medication can cause serious risks to the fetus during pregnancy, particularly in the second and third trimesters; therefore, its use should be avoided during pregnancy. This medication is prohibited for patients with allergies to its components or with specific liver or kidney diseases. Elderly patients or those with heart, liver, or kidney diseases should use this medication with greater caution. This medication lowers blood pressure and may occasionally cause dizziness or hypotensive symptoms, so take care when driving or operating machinery. The Hydrochlorothiazide component can cause electrolyte imbalances; therefore, electrolyte levels should be regularly monitored through blood tests during treatment. Those taking this medication should be cautious about sun exposure, as it may cause skin sensitivity, thus sunscreen should be applied adequately. Interactions may occur when used with other antihypertensive or certain medications, so consultation with a doctor or pharmacist is essential. In the case of overdose, symptoms such as hypotension, electrolyte abnormalities, and dehydration may occur, requiring immediate medical consultation. It is advised that children under 18 years of age do not take this medication. This medication should be kept out of reach of children and should not be transferred to another container.
Hypotension, reduced cranial formation in neonates, anuria, renal failure, oligohydramnios, limb spasms, craniofacial malformation, hypoplasia of the lungs, prematurity, intrauterine growth retardation, patent ductus arteriosus, bronchitis, pharyngitis, sinusitis, exacerbation or activation of systemic lupus erythematosus, hypokalemia, hyperuricemia, hyponatremia, anxiety, depression, dizziness, syncope, sensory abnormalities, insomnia, sleep disturbances, visual disturbances, transient blurring of vision, vertigo, tachycardia, arrhythmia, hypotension, orthostatic hypotension, dyspnea, pneumonia, pulmonary edema, diarrhea, dry mouth, abdominal distension, abdominal pain, constipation, dyspepsia, vomiting, gastritis, abnormal liver function, liver impairment, angioedema, erythema, itching, rash, increased sweating, urticaria, low back pain, muscle spasm, myalgia, arthralgia, limb pain, erectile dysfunction, chest pain, influenza-like illnesses, pain, increased blood uric acid, increased blood creatinine, increased blood creatine phosphokinase, increased liver enzymes, upper respiratory infection, urinary tract infection, sepsis, anemia, eosinophilia, thrombocytopenia, anaphylactic reaction, hypersensitivity, hyperkalemia, hypoglycemia, bradycardia, abdominal discomfort, eczema, drug rash, toxic skin rash, joint disease, tendon pain, renal impairment, weakness, decreased hemoglobin, sialadenitis, aplastic anemia, hemolytic anemia, bone marrow failure, leukopenia, neutropenia, agranulocytosis, necrotizing vasculitis, pancreatitis, abdominal discomfort, hepatocellular jaundice, cholestatic jaundice, toxic epidermal necrolysis, lupus erythematosus-like reaction, cutaneous vasculitis, photosensitivity reaction, reactivation of lupus erythematosus, frailty, interstitial nephritis, impaired kidney function, diabetes, fever, increased triglycerides, acute respiratory distress syndrome, nausea, gastrointestinal bleeding, esophagitis, headache, tremor, facial flushing, lethargy, fatigue, weight loss, proteinuria, itching, myalgia, sense of floating, lip and hand tremors, hyperesthesia, gum disease, dry lips, decreased vision, hypoglycemia, acute myopia, acute closed-angle glaucoma, dyspnea, fever, worsening lung condition, hypotension
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air and moisture. It is best to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature to preserve the medication's efficacy for a longer period.
White or off-white, biconvex, round tablet
10 tablets/blister X 3, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Telmisartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
CombinationTelmisartan 40mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Hanmi Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.